BACKGROUND AND OBJECTIVES: Despite advances in prevention of acute rejection and improved short- and long-term kidney graft survival, recurrent glomerulonephritis remains problematic and poorly characterized. This study analyzed prevalence and outcome of recurrent glomerulonephritis from various registries. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: Definition, classification, and limitations in evaluating epidemiology of native and recurrent glomerulonephritis are discussed. Epidemiology of native glomerulonephritis as the cause of end-stage renal failure and subsequent recurrence of individual glomerulonephritis was evaluated using data from various registries, and pathogenesis of individual glomerulonephritis is discussed. RESULTS: Analysis of data from transplant registries revealed that glomerulonephritis is an important cause of end-stage renal disease in white and pediatric recipients; however, glomerulonephritis as the cause of end-stage renal disease is not characterized well in black recipients, and many of them are perhaps labeled to have hypertensive nephrosclerosis as the cause of renal disease without renal biopsy. A systematic approach toward urinalysis after transplantation and utility of immunofluorescence and electron microscopic examination of renal biopsy tissues will identify the true prevalence of recurrent glomerulonephritis. Data on recurrent glomerulonephritis should be compiled by either using registry analysis or pooling data from multiple centers. This will provide true data on prevalence and outcome and could potentially initiate translational research studies. CONCLUSIONS: The understanding of the pathogenesis of recurrent glomerulonephritis is critical to optimize prevention as well as to treat individual recurrent glomerulonephritis, which can enhance long-term graft survival.
BACKGROUND AND OBJECTIVES: Despite advances in prevention of acute rejection and improved short- and long-term kidney graft survival, recurrent glomerulonephritis remains problematic and poorly characterized. This study analyzed prevalence and outcome of recurrent glomerulonephritis from various registries. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: Definition, classification, and limitations in evaluating epidemiology of native and recurrent glomerulonephritis are discussed. Epidemiology of native glomerulonephritis as the cause of end-stage renal failure and subsequent recurrence of individual glomerulonephritis was evaluated using data from various registries, and pathogenesis of individual glomerulonephritis is discussed. RESULTS: Analysis of data from transplant registries revealed that glomerulonephritis is an important cause of end-stage renal disease in white and pediatric recipients; however, glomerulonephritis as the cause of end-stage renal disease is not characterized well in black recipients, and many of them are perhaps labeled to have hypertensive nephrosclerosis as the cause of renal disease without renal biopsy. A systematic approach toward urinalysis after transplantation and utility of immunofluorescence and electron microscopic examination of renal biopsy tissues will identify the true prevalence of recurrent glomerulonephritis. Data on recurrent glomerulonephritis should be compiled by either using registry analysis or pooling data from multiple centers. This will provide true data on prevalence and outcome and could potentially initiate translational research studies. CONCLUSIONS: The understanding of the pathogenesis of recurrent glomerulonephritis is critical to optimize prevention as well as to treat individual recurrent glomerulonephritis, which can enhance long-term graft survival.
Authors: K C Abbott; E S Sawyers; J D Oliver; C W Ko; A D Kirk; P G Welch; T G Peters; L Y Agodoa Journal: Am J Kidney Dis Date: 2001-02 Impact factor: 8.860
Authors: R Dall'Amico; G Ghiggeri; M Carraro; M Artero; L Ghio; E Zamorani; C Zennaro; G Basile; G Montini; L Rivabella; M Cardillo; M Scalamogna; F Ginevri Journal: Am J Kidney Dis Date: 1999-12 Impact factor: 8.860
Authors: Y S Kim; J I Moon; H J Jeong; M S Kim; S I Kim; K H Choi; H Y Lee; D S Han; K Park Journal: Transplantation Date: 2001-01-27 Impact factor: 4.939
Authors: P Cochat; A Kassir; S Colon; C Glastre; B Tourniaire; B Parchoux; X Martin; L David Journal: Pediatr Nephrol Date: 1993-02 Impact factor: 3.714
Authors: David K C Cooper; Martin Wijkstrom; Sundaram Hariharan; Joshua L Chan; Avneesh Singh; Keith Horvath; Muhammad Mohiuddin; Arielle Cimeno; Rolf N Barth; John C LaMattina; Richard N Pierson Journal: Transplantation Date: 2017-07 Impact factor: 4.939
Authors: Rashmi D Patel; Aruna V Vanikar; Lovelesh A Nigam; Kamal V Kanodia; Kamlesh S Suthar; Himanshu V Patel Journal: J Clin Diagn Res Date: 2017-04-01
Authors: Jesse D Schold; Joshua J Augustine; Anne M Huml; Richard Fatica; Saul Nurko; Alvin Wee; Emilio D Poggio Journal: Am J Transplant Date: 2020-08-27 Impact factor: 8.086